Allergan Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia

NORTH CHICAGO, Ill., Feb. 25, 2021 /PRNewswire/ -- Allergan, an AbbVie (NYSE: ABBV) company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for investigational AGN-190584...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news